Skip to content
OpenCapital
Get started

Journey Medical Corporation DERM Gain (Loss), Foreign Currency Transaction, before Tax

Gain (Loss), Foreign Currency Transaction, before Tax at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
——

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M—
Free cash flow-$6.0M—

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S3×+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%—
Net margin-14.8%—
FCF margin-43%—

Returns & leverage

See full
Return on equity-36.6%—
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's gain (loss), foreign currency transaction, before tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's gain (loss), foreign currency transaction, before tax?
Journey Medical Corporation (DERM) reported gain (loss), foreign currency transaction, before tax of -$3K in Q1 2026.
How has Journey Medical Corporation's gain (loss), foreign currency transaction, before tax changed year-over-year?
Journey Medical Corporation's gain (loss), foreign currency transaction, before tax increased by 57.1% year-over-year, from -$7K to -$3K.
What is the long-term trend for Journey Medical Corporation's gain (loss), foreign currency transaction, before tax?
Over 2 years (2023 to 2025), Journey Medical Corporation's gain (loss), foreign currency transaction, before tax has grown at a -29.9% compound annual growth rate (CAGR), from -$183K to -$90K.